![Pete Kang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Pete Kang worked as a Director at Quadrant Biosciences, Inc. and as a Vice President at TStone Corp.
in 2012.
Precedenti posizioni note di Pete Kang
| Società | Posizione | Fine |
|---|---|---|
TStone Corp.
 TStone Corp. Investment ManagersFinance Tstone is an active manager which provides equity funding for buyout stage capital requirement. The firm targets companies operating in industries such as education, digital content, primarily targeting online games, online education, media/entertainment and related infrastructure and technology with enterprise value under KRW 500 billion. TStone typically takes majority stakes and sit in board seat. | Investitore di Private Equity | 31/12/2012 |
Quadrant Biosciences, Inc.
 Quadrant Biosciences, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
4
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
TStone Corp.
TStone Corp. Investment ManagersFinance Tstone is an active manager which provides equity funding for buyout stage capital requirement. The firm targets companies operating in industries such as education, digital content, primarily targeting online games, online education, media/entertainment and related infrastructure and technology with enterprise value under KRW 500 billion. TStone typically takes majority stakes and sit in board seat. | Finance |
Quadrant Biosciences, Inc.
Quadrant Biosciences, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
